MRA: Current Applications in Body Vascular Imaging

Advantages of MRA over CTA include increased signalto-noise ratio, easier 3D postprocessing, and utility in patients with renal dysfunction, such as diabetics [2,3]. In patients who require recurrent follow-up imaging, MRA is superior, given its lack of ionizing radiation. MRA is often used to image...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian Association of Radiologists journal 2009-06, Vol.60 (3), p.133-142
Hauptverfasser: Ciura, Viesha A., MD, Lee, Mark J., MD, Schemmer, Drew C., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 142
container_issue 3
container_start_page 133
container_title Canadian Association of Radiologists journal
container_volume 60
creator Ciura, Viesha A., MD
Lee, Mark J., MD
Schemmer, Drew C., MD
description Advantages of MRA over CTA include increased signalto-noise ratio, easier 3D postprocessing, and utility in patients with renal dysfunction, such as diabetics [2,3]. In patients who require recurrent follow-up imaging, MRA is superior, given its lack of ionizing radiation. MRA is often used to image the visceral aortic branches and in many centers is the gold standard for visualizing the renal arteries. MRA has also been shown to be valuable in the preprocedural and follow-up of patients undergoing aortic EVAR. In the planning stages, CE-MRA has been shown not only to be as accurate as CTA but able to provide functional, hemodynamic information that CTA cannot. As well, common delayed complications, for example, endoleak, are more conspicuous with contrast-enhanced MRA [8]. Other applications of MRA include cerebrovascular imaging and visualization of the infrainguinal arterial system [2]. Conventional angiography has traditionally been the gold standard for imaging vascular TOS because of its high resolution, however, it is invasive, requires the use of iodinated contrast, and does not always allow the cause of the compression to be determined [13]. MRA is perfectly suited to the imaging of vascular TOS, with its high spatial resolution, noninvasiveness, and short acquisition times [14]. Use of MRA to evaluate TOS requires 2 positions, neutral and challenged, and 2 separate contrast injections, but can be dynamically interrogated by using TRICKS or TWIST techniques. TRICKS in real time is demonstrated in Video 1. Dynamic MRA avoids the potential for residual intravascular contrast contaminations and reduced signal-to-noise ratios. Two separate static MRA studies examined this potential pitfall and concluded that image quality was. rarely impaired by the increased background contrast, because they were able to achieve detailed images of both the arteries and veins in both arm positions [11,15]. MRA, with its superior softtissue imaging capabilities, has the distinct advantage of demonstrating the underlying cause of TOS, whether it is congenital bony or fibromuscular anomalies, trauma, or posture. Ultimately, TOS is a surgical and/or clinical diagnosis, and a multidisciplinary approach is paramount. It has been suggested that diagnostic utility of MRA and CTA in detecting PAD is variable, depending on the anatomic level of the disease and the degree of venous contamination [17,18]. The infrapopliteal region is poorly visualized by CTA because of the small-
doi_str_mv 10.1016/j.carj.2009.05.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67476680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0846537109001053</els_id><sourcerecordid>1800447391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-8a054451471226ad79636f7912e4903834c40647e3cc0940bfbf6b76eb9dfb0e3</originalsourceid><addsrcrecordid>eNp9kUtP3DAUha0KVKa0f4AFiliwS7h-xI6rCmkYQUECIfW1tRznBjlkksFOKs2_b6IZUYkFK2--c3T9HUJOKGQUqLxoMmdDkzEAnUGeARQfyIKKokgZl_SALKAQMs25okfkU4wNAAiu9EdyRHWuqZJiQdjDj-XXZDWGgN2QLDeb1js7-L6Lie-Sq77aJn9sdGNrQ3K3tk--e_pMDmvbRvyyf4_J75vrX6vb9P7x-91qeZ86weWQFhZyIXIqFGVM2kppyWWtNGUoNPCCCydACoXcOdACyrqsZakklrqqS0B-TM53vZvQv4wYB7P20WHb2g77MRqphJKygAk8ewM2_Ri66TbDeK4LITSdILaDXOhjDFibTfBrG7aGgpl1msbMOs2s00BuJp1T6HTfPJZrrP5H9v4m4NsOwEnEX4_BROexc1j5gG4wVe_f7798E3et76YF2mfcYnz9BjWRGTA_50HnPUEDUMg5_weGc5e2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>235984491</pqid></control><display><type>article</type><title>MRA: Current Applications in Body Vascular Imaging</title><source>Access via SAGE</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via ScienceDirect (Elsevier)</source><creator>Ciura, Viesha A., MD ; Lee, Mark J., MD ; Schemmer, Drew C., MD</creator><creatorcontrib>Ciura, Viesha A., MD ; Lee, Mark J., MD ; Schemmer, Drew C., MD</creatorcontrib><description>Advantages of MRA over CTA include increased signalto-noise ratio, easier 3D postprocessing, and utility in patients with renal dysfunction, such as diabetics [2,3]. In patients who require recurrent follow-up imaging, MRA is superior, given its lack of ionizing radiation. MRA is often used to image the visceral aortic branches and in many centers is the gold standard for visualizing the renal arteries. MRA has also been shown to be valuable in the preprocedural and follow-up of patients undergoing aortic EVAR. In the planning stages, CE-MRA has been shown not only to be as accurate as CTA but able to provide functional, hemodynamic information that CTA cannot. As well, common delayed complications, for example, endoleak, are more conspicuous with contrast-enhanced MRA [8]. Other applications of MRA include cerebrovascular imaging and visualization of the infrainguinal arterial system [2]. Conventional angiography has traditionally been the gold standard for imaging vascular TOS because of its high resolution, however, it is invasive, requires the use of iodinated contrast, and does not always allow the cause of the compression to be determined [13]. MRA is perfectly suited to the imaging of vascular TOS, with its high spatial resolution, noninvasiveness, and short acquisition times [14]. Use of MRA to evaluate TOS requires 2 positions, neutral and challenged, and 2 separate contrast injections, but can be dynamically interrogated by using TRICKS or TWIST techniques. TRICKS in real time is demonstrated in Video 1. Dynamic MRA avoids the potential for residual intravascular contrast contaminations and reduced signal-to-noise ratios. Two separate static MRA studies examined this potential pitfall and concluded that image quality was. rarely impaired by the increased background contrast, because they were able to achieve detailed images of both the arteries and veins in both arm positions [11,15]. MRA, with its superior softtissue imaging capabilities, has the distinct advantage of demonstrating the underlying cause of TOS, whether it is congenital bony or fibromuscular anomalies, trauma, or posture. Ultimately, TOS is a surgical and/or clinical diagnosis, and a multidisciplinary approach is paramount. It has been suggested that diagnostic utility of MRA and CTA in detecting PAD is variable, depending on the anatomic level of the disease and the degree of venous contamination [17,18]. The infrapopliteal region is poorly visualized by CTA because of the small-diameter arteries [19], and highly calcified vessels are the nemesis of CTA luminal evaluation. MRA contrast media fills the vessel lumen, and the inherent MR and subtraction techniques circumvent calcification artifacts, altogether making its utility in patients with diabetes and with calcified vessels superior to CTA and DSA. Also, dynamic MRA techniques can replicate real-time inflow of contrast media, as in DSA, and show superior vessel analysis of stenoses, compared with standard, nondirectional, MRA and CTA techniques. Examples of the dynamic nature of MRA and its utility in evaluating PAD are seen in Figure 3 and Videos 2 and 3. Also, the sequelae of atherosclerosis is demonstrated in Video 4, but the case involves the vessels of the wrist and hand.</description><identifier>ISSN: 0846-5371</identifier><identifier>EISSN: 1488-2361</identifier><identifier>DOI: 10.1016/j.carj.2009.05.008</identifier><identifier>PMID: 19591764</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Contrast Media ; Humans ; Magnetic Resonance Angiography - methods ; Medical diagnosis ; NMR ; Nuclear magnetic resonance ; Radiology ; Vascular Diseases - diagnosis ; Vascular Diseases - pathology ; Veins &amp; arteries</subject><ispartof>Canadian Association of Radiologists journal, 2009-06, Vol.60 (3), p.133-142</ispartof><rights>Canadian Association of Radiologists</rights><rights>2009 Canadian Association of Radiologists</rights><rights>Copyright Canadian Association of Radiologists Jun 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-8a054451471226ad79636f7912e4903834c40647e3cc0940bfbf6b76eb9dfb0e3</citedby><cites>FETCH-LOGICAL-c436t-8a054451471226ad79636f7912e4903834c40647e3cc0940bfbf6b76eb9dfb0e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.carj.2009.05.008$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19591764$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ciura, Viesha A., MD</creatorcontrib><creatorcontrib>Lee, Mark J., MD</creatorcontrib><creatorcontrib>Schemmer, Drew C., MD</creatorcontrib><title>MRA: Current Applications in Body Vascular Imaging</title><title>Canadian Association of Radiologists journal</title><addtitle>Can Assoc Radiol J</addtitle><description>Advantages of MRA over CTA include increased signalto-noise ratio, easier 3D postprocessing, and utility in patients with renal dysfunction, such as diabetics [2,3]. In patients who require recurrent follow-up imaging, MRA is superior, given its lack of ionizing radiation. MRA is often used to image the visceral aortic branches and in many centers is the gold standard for visualizing the renal arteries. MRA has also been shown to be valuable in the preprocedural and follow-up of patients undergoing aortic EVAR. In the planning stages, CE-MRA has been shown not only to be as accurate as CTA but able to provide functional, hemodynamic information that CTA cannot. As well, common delayed complications, for example, endoleak, are more conspicuous with contrast-enhanced MRA [8]. Other applications of MRA include cerebrovascular imaging and visualization of the infrainguinal arterial system [2]. Conventional angiography has traditionally been the gold standard for imaging vascular TOS because of its high resolution, however, it is invasive, requires the use of iodinated contrast, and does not always allow the cause of the compression to be determined [13]. MRA is perfectly suited to the imaging of vascular TOS, with its high spatial resolution, noninvasiveness, and short acquisition times [14]. Use of MRA to evaluate TOS requires 2 positions, neutral and challenged, and 2 separate contrast injections, but can be dynamically interrogated by using TRICKS or TWIST techniques. TRICKS in real time is demonstrated in Video 1. Dynamic MRA avoids the potential for residual intravascular contrast contaminations and reduced signal-to-noise ratios. Two separate static MRA studies examined this potential pitfall and concluded that image quality was. rarely impaired by the increased background contrast, because they were able to achieve detailed images of both the arteries and veins in both arm positions [11,15]. MRA, with its superior softtissue imaging capabilities, has the distinct advantage of demonstrating the underlying cause of TOS, whether it is congenital bony or fibromuscular anomalies, trauma, or posture. Ultimately, TOS is a surgical and/or clinical diagnosis, and a multidisciplinary approach is paramount. It has been suggested that diagnostic utility of MRA and CTA in detecting PAD is variable, depending on the anatomic level of the disease and the degree of venous contamination [17,18]. The infrapopliteal region is poorly visualized by CTA because of the small-diameter arteries [19], and highly calcified vessels are the nemesis of CTA luminal evaluation. MRA contrast media fills the vessel lumen, and the inherent MR and subtraction techniques circumvent calcification artifacts, altogether making its utility in patients with diabetes and with calcified vessels superior to CTA and DSA. Also, dynamic MRA techniques can replicate real-time inflow of contrast media, as in DSA, and show superior vessel analysis of stenoses, compared with standard, nondirectional, MRA and CTA techniques. Examples of the dynamic nature of MRA and its utility in evaluating PAD are seen in Figure 3 and Videos 2 and 3. Also, the sequelae of atherosclerosis is demonstrated in Video 4, but the case involves the vessels of the wrist and hand.</description><subject>Contrast Media</subject><subject>Humans</subject><subject>Magnetic Resonance Angiography - methods</subject><subject>Medical diagnosis</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Radiology</subject><subject>Vascular Diseases - diagnosis</subject><subject>Vascular Diseases - pathology</subject><subject>Veins &amp; arteries</subject><issn>0846-5371</issn><issn>1488-2361</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kUtP3DAUha0KVKa0f4AFiliwS7h-xI6rCmkYQUECIfW1tRznBjlkksFOKs2_b6IZUYkFK2--c3T9HUJOKGQUqLxoMmdDkzEAnUGeARQfyIKKokgZl_SALKAQMs25okfkU4wNAAiu9EdyRHWuqZJiQdjDj-XXZDWGgN2QLDeb1js7-L6Lie-Sq77aJn9sdGNrQ3K3tk--e_pMDmvbRvyyf4_J75vrX6vb9P7x-91qeZ86weWQFhZyIXIqFGVM2kppyWWtNGUoNPCCCydACoXcOdACyrqsZakklrqqS0B-TM53vZvQv4wYB7P20WHb2g77MRqphJKygAk8ewM2_Ri66TbDeK4LITSdILaDXOhjDFibTfBrG7aGgpl1msbMOs2s00BuJp1T6HTfPJZrrP5H9v4m4NsOwEnEX4_BROexc1j5gG4wVe_f7798E3et76YF2mfcYnz9BjWRGTA_50HnPUEDUMg5_weGc5e2</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>Ciura, Viesha A., MD</creator><creator>Lee, Mark J., MD</creator><creator>Schemmer, Drew C., MD</creator><general>Elsevier Inc</general><general>SAGE PUBLICATIONS, INC</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7U5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>L7M</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M3G</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PADUT</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20090601</creationdate><title>MRA: Current Applications in Body Vascular Imaging</title><author>Ciura, Viesha A., MD ; Lee, Mark J., MD ; Schemmer, Drew C., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-8a054451471226ad79636f7912e4903834c40647e3cc0940bfbf6b76eb9dfb0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Contrast Media</topic><topic>Humans</topic><topic>Magnetic Resonance Angiography - methods</topic><topic>Medical diagnosis</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Radiology</topic><topic>Vascular Diseases - diagnosis</topic><topic>Vascular Diseases - pathology</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ciura, Viesha A., MD</creatorcontrib><creatorcontrib>Lee, Mark J., MD</creatorcontrib><creatorcontrib>Schemmer, Drew C., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business &amp; Current Affairs Database</collection><collection>Canadian Business &amp; Current Affairs Database (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>CBCA Reference &amp; Current Events</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Research Library China</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian Association of Radiologists journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ciura, Viesha A., MD</au><au>Lee, Mark J., MD</au><au>Schemmer, Drew C., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MRA: Current Applications in Body Vascular Imaging</atitle><jtitle>Canadian Association of Radiologists journal</jtitle><addtitle>Can Assoc Radiol J</addtitle><date>2009-06-01</date><risdate>2009</risdate><volume>60</volume><issue>3</issue><spage>133</spage><epage>142</epage><pages>133-142</pages><issn>0846-5371</issn><eissn>1488-2361</eissn><abstract>Advantages of MRA over CTA include increased signalto-noise ratio, easier 3D postprocessing, and utility in patients with renal dysfunction, such as diabetics [2,3]. In patients who require recurrent follow-up imaging, MRA is superior, given its lack of ionizing radiation. MRA is often used to image the visceral aortic branches and in many centers is the gold standard for visualizing the renal arteries. MRA has also been shown to be valuable in the preprocedural and follow-up of patients undergoing aortic EVAR. In the planning stages, CE-MRA has been shown not only to be as accurate as CTA but able to provide functional, hemodynamic information that CTA cannot. As well, common delayed complications, for example, endoleak, are more conspicuous with contrast-enhanced MRA [8]. Other applications of MRA include cerebrovascular imaging and visualization of the infrainguinal arterial system [2]. Conventional angiography has traditionally been the gold standard for imaging vascular TOS because of its high resolution, however, it is invasive, requires the use of iodinated contrast, and does not always allow the cause of the compression to be determined [13]. MRA is perfectly suited to the imaging of vascular TOS, with its high spatial resolution, noninvasiveness, and short acquisition times [14]. Use of MRA to evaluate TOS requires 2 positions, neutral and challenged, and 2 separate contrast injections, but can be dynamically interrogated by using TRICKS or TWIST techniques. TRICKS in real time is demonstrated in Video 1. Dynamic MRA avoids the potential for residual intravascular contrast contaminations and reduced signal-to-noise ratios. Two separate static MRA studies examined this potential pitfall and concluded that image quality was. rarely impaired by the increased background contrast, because they were able to achieve detailed images of both the arteries and veins in both arm positions [11,15]. MRA, with its superior softtissue imaging capabilities, has the distinct advantage of demonstrating the underlying cause of TOS, whether it is congenital bony or fibromuscular anomalies, trauma, or posture. Ultimately, TOS is a surgical and/or clinical diagnosis, and a multidisciplinary approach is paramount. It has been suggested that diagnostic utility of MRA and CTA in detecting PAD is variable, depending on the anatomic level of the disease and the degree of venous contamination [17,18]. The infrapopliteal region is poorly visualized by CTA because of the small-diameter arteries [19], and highly calcified vessels are the nemesis of CTA luminal evaluation. MRA contrast media fills the vessel lumen, and the inherent MR and subtraction techniques circumvent calcification artifacts, altogether making its utility in patients with diabetes and with calcified vessels superior to CTA and DSA. Also, dynamic MRA techniques can replicate real-time inflow of contrast media, as in DSA, and show superior vessel analysis of stenoses, compared with standard, nondirectional, MRA and CTA techniques. Examples of the dynamic nature of MRA and its utility in evaluating PAD are seen in Figure 3 and Videos 2 and 3. Also, the sequelae of atherosclerosis is demonstrated in Video 4, but the case involves the vessels of the wrist and hand.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>19591764</pmid><doi>10.1016/j.carj.2009.05.008</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0846-5371
ispartof Canadian Association of Radiologists journal, 2009-06, Vol.60 (3), p.133-142
issn 0846-5371
1488-2361
language eng
recordid cdi_proquest_miscellaneous_67476680
source Access via SAGE; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via ScienceDirect (Elsevier)
subjects Contrast Media
Humans
Magnetic Resonance Angiography - methods
Medical diagnosis
NMR
Nuclear magnetic resonance
Radiology
Vascular Diseases - diagnosis
Vascular Diseases - pathology
Veins & arteries
title MRA: Current Applications in Body Vascular Imaging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T09%3A28%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MRA:%20Current%20Applications%20in%20Body%20Vascular%20Imaging&rft.jtitle=Canadian%20Association%20of%20Radiologists%20journal&rft.au=Ciura,%20Viesha%20A.,%20MD&rft.date=2009-06-01&rft.volume=60&rft.issue=3&rft.spage=133&rft.epage=142&rft.pages=133-142&rft.issn=0846-5371&rft.eissn=1488-2361&rft_id=info:doi/10.1016/j.carj.2009.05.008&rft_dat=%3Cproquest_cross%3E1800447391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=235984491&rft_id=info:pmid/19591764&rft_els_id=1_s2_0_S0846537109001053&rfr_iscdi=true